Bank of New York Mellon
NURO

Bank of New York Mellon’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bank of New York Mellon’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-355
Closed -$58K – 4411
2017
Q3 		$58K Hold
355
– – ﹤0.01% 4089
2017
Q2 		$76K Buy
355
+324
+1,045% +$101K ﹤0.01% 4075
2017
Q1 		$12K Buy
+31
New +$13.4K ﹤0.01% 4252

Other funds holding NURO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon's NURO Position: Q4 2017 in Review

Bank of New York Mellon sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2017, closing a stake of 355 shares — an estimated $58K sold.

Bank of New York Mellon first reported a position in NURO in Q1 2017 and held it in 3 quarters. The position peaked at $76K in Q2 2017. 8 funds tracked by Wall St. Rank hold NURO as of Q4 2017.

  • Bank of New York Mellon reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 355 NeuroMetrix, Inc. Common Stock shares in Q4 2017, an estimated $58K.
  • Bank of New York Mellon first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2017 and held it in 3 quarters.
  • Bank of New York Mellon's NeuroMetrix, Inc. Common Stock position peaked at $76K in Q2 2017.
  • 8 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2017.

Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.